Factors directly affecting impulse transmission in inflammatory demyelinating disease: Recent advances in our understanding

Current Opinion in Neurology

Volumn 14, Issue 3, 2001, Pages 289-298

  Smith, Kenneth J ^a   Hall, Susan M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GANGLIOSIDE ANTIBODY; GLUTAMIC ACID; ION CHANNEL; NITRIC OXIDE; PYRROCAINE;

BLOOD BRAIN BARRIER; DEMYELINATING DISEASE; DEMYELINATION; GUILLAIN BARRE SYNDROME; HUMAN; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NERVE EXCITABILITY; NERVE FIBER DEGENERATION; NERVE FIBER MEMBRANE; REVIEW; SYNAPTIC TRANSMISSION;

AUTOANTIBODIES; AXONS; BLOOD-BRAIN BARRIER; BRAIN; CYTOKINES; GLUTAMIC ACID; GUILLAIN-BARRE SYNDROME; HUMANS; MEMBRANE POTENTIALS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NITRIC OXIDE; SYNAPTIC TRANSMISSION;

EID: 0034987439     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200106000-00005     Document Type: Review

References (165)

1. Review of axonal loss
2. The pathophysiology of multiple sclerosis: The mechanisms underlying the production of symptoms and the natural history of the disease
3. Review of demyelination
4. Inflammatory mediators and modulation of blood-brain barrier permeability
5. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electro-physiological deficits
6. Lesion development in Marburg's type of acute multiple sclerosis: From inflammation to demyelination
7. Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders
8. The potential role of nitric oxide in multiple sclerosis
9. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis
10. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
11. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
12. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
13. Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especially susceptible
14. Temporary axonal conduction block and axonal loss in inflammatory neurological disease: A potential role for nitric oxide?
15. Nerve conduction block by nitric oxide that is mediated by the axonal environment
16. Induction of persistent sodium current by exogenous and endogenous nitric oxide
17. Nitric oxide is an autocrine regulator of Na+ currents in axotomized C-type DRG neurons
18. Nitric oxide enhances slow inactivation of voltage-dependent sodium currents in rat nodose neurons
19. Inhibition of amiloride-sensitive sodium-channel activity in distal lung epithelial cells by nitric oxide
20. Peroxynitrite inhibits amiloride-sensitive Na+ currents in Xenopus oocytes expressing alphabetagamma-rENaC
21. Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons
22. Direct actions of nitric oxide on rat neurohypophysial K+ channels
23. Nitric oxide activates Ca2+-activated K+ channels in cultured bovine adrenal chromaffin cells
24. Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein
25. Nitric oxide tonically depresses a voltage- and Ca-dependent outward current in hippocampal slices
26. Nitric oxide and cGMP modulate a presynaptic K+ channel in vitro
27. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
28. Nitric oxide reduces Ca2+ and Zn2+ influx through voltage-gated Ca2+ channels and reduces Zn2+ neurotoxicity
29. Nitric oxide increases excitability by depressing a calcium activated potassium current in snail neurons
30. Mechanism of nitric oxide toxicity to CNS white matter axons
31. Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases
32. Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability
33. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review
34. A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis
35. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis
36. Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: Aminoguanidine treatment modifies its clinical evolution
37. Aminoguanidine-induced amelioration of autoimmune encephalomyelitis is mediated by reduced expression of inducible nitric oxide synthase in the spinal cord
38. Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid
39. Pretreatment of astrocytes with interferon-alpha/beta prevents neuronal mitochondrial respiratory chain damage
40. Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase
41. Selective inhibition of human glial inducible nitric oxide synthase by interferon-beta: Implications for multiple sclerosis
42. Interferon beta-1b inhibits reactive oxygen species production in peripheral blood monocytes of patients with relapsing-remitting multiple sclerosis
43. Demyelination: The role of reactive oxygen and nitrogen species
44. On the nature of endogenous antiexcitatory factors in the cerebrospinal fluid of patients with demyelinating neurological disease
45. The small sodium-channel blocking factor in the cerebrospinal fluid of multiple sclerosis patients is probably an oligopeptide
46. An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system
47. Do 'demyelinating' diseases involve more than myelin?
48. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
49. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
50. Local anaesthetic-like effect of interleukin-2 on muscular Na+ channels: No evidence for involvement of the IL-2 receptor
51. Mechanisms of hyperpolarization induced by two cytokines, hTNF alpha and hIL-1 alpha in neurons of the mollusc, Onchidium
52. Early and long term effects of interferon-γ (IFN-γ) on inward-rectifying K+ channels in rat microglia
53. Effects of tumor necrosis factor on inward potassium current and cell morphology in cultured human oligodendrocytes
54. Interleukin-1 beta depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations
55. Bacterial lipopolysaccharide induces a conduction block in the sciatic nerves of rats
56. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis
57. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
58. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome
59. Failure of anti-GM1 IgC or IgM to induce conduction block following intraneural transfer
60. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro
61. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller-Fisher syndrome
62. The distribution of ganglioside-like moieties in peripheral nerves
63. The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro
64. Acute conduction block in vitro following exposure to antiganglioside sera
65. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons
66. Immune-mediated peripheral neuropathies and voltage-gated sodium channels
67. Anti-GM1 antibodies can block neuronal voltage-gated sodium channels
68. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers
69. Neonatal Guillain-Barré syndrome: Blocking antibodies transmitted from mother to child
70. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: A macro-patch-clamp study
71. Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals
72. Miller-Fisher anti-GQ1b antibodies: Alpha-Latrotoxin-like effects on motor end plates
73. Anti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model
74. On the molecular architecture of myelinated fibers
75. Ion channel sequestration in central nervous system axons
76. Molecular domains of myelinated axons
77. Clustering of neuronal sodium channels requires contact with myelinating Schwann cells
78. Induction of sodium channel clustering by oligodendrocytes
79. Dependence of nodal sodium channel clustering on paranodal axoglial contact in the developing CNS
80. Physiological roles of axonal ankyrins in survival of premyelinated axons and localization of voltage-gated sodium channels
81. Morphogenesis of the node of Ranvier: Co-clusters of ankyrin and ankyrin-binding integral proteins define early developmental intermediates
82. Changes of ionic channel distribution in myelinated nerve fibres from rats with experimental allergic neuritis
83. Disruption and reorganization of sodium channels in experimental allergic neuritis
84. Interleukin-2 inhibits sodium currents in human muscle cells
85. Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
86. Sodium channel internalization in developing neurons
87. Sodium and potassium channel immunolocalisation in demyelinated and remyelinated central axons
88. Sodium channel Na(v)1.6 is localized at nodes of Ranvier, dendrites, and synapses
89. Excitability changes of dorsal root axons following nerve injury: Implications for injury-induced changes in axonal Na+ channels
90. Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons
91. Glial-derived neurotrophic factor upregulates expression of functional SNS and NaN sodium channels and their currents in axotomized dorsal root ganglion neurons
92. Alteration of Na+ currents in dorsal root ganglion neurons from rats with a painful neuropathy
93. Beta3, a novel auxiliary subunit for the voltage-gated sodium channel, is expressed preferentially in sensory neurons and is upregulated in the chronic constriction injury model of neuropathic pain
94. Changes in expression of two tetrodotoxin-resistant sodium channels and their currents in dorsal root ganglion neurons after sciatic nerve injury but not rhizotomy
95. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain
96. Abnormal expression of SNS/PN3 sodium channel in cerebellar Purkinje cells following loss of myelin in the taiep rat
97. The sodium channel auxiliary subunits beta1 and beta2 are differentially expressed in the spinal cord of neuropathic rats
98. Rapid sodium channel augmentation in response to inflammation induced by complete Freund's adjuvant
99. Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis
100. Myelinating Schwann cells determine the internodal localization of Ky1.1, Ky1.2, Kvbeta2, and Caspr
101. Completion of myelin compaction, but not the attachment of oligodendroglial processes triggers K+ channel clustering
102. K+ channel distribution and clustering in developing and hypomyelinated axons of the optic nerve
103. Axo-glial interactions regulate the localization of axonal paranodal proteins
104. Identification of autoantibodies associated with myelin damage in multiple sclerosis
105. Pathogenetic role of autoantibodies in neurological diseases
106. B cells and antibodies in CNS demyelinating disease
107. Potassium channel distribution, clustering, and function in remyelinating rat axons
108. Hypomyelination alters K+ channel expression in mouse mutants shiverer and Trembler
109. Changes in expression of voltage-gated potassium channels in dorsal root ganglion neurons following axotomy
110. Distribution of calcium channel subunits in dystrophic axons of multiple sclerosis and experimental autoimmune encephaloymyelitis
111. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome
112. Excitability properties of median and peroneal motor axons
113. Analysis of potassium channel functions in mammalian axons by gene knockouts
114. Axonal hyperexcitability: Mechanisms and role in symptom production in demyelinating diseases
115. Mechanisms of paresthesias arising from healthy axons
116. Axonal flip-flops and oscillators
117. Ectopic mechanosensitivity in injured sensory axons arises from the site of spontaneous electrogenesis
118. Continuous facial myokymia in multiple sclerosis: Treatment with botulinum toxin
119. Ectopic activity in demyelinated spinal root axons of the rat
120. Slow sodium-dependent potential oscillations contribute to ectopic firing in mammalian demyelinated axons
121. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres
122. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat
123. Electrical interactions via the extracellular potential near cell bodies
124. Cross-excitation in dorsal root ganglia does not depend on close cell-to-cell apposition
125. Trigeminal neuralgia triggered by auditory stimuli in multiple sclerosis
126. Activity-dependent excitability changes in normal and demyelinated rat spinal root axons
127. A mechanism for ectopic firing in central demyelinated axons
128. Quantitative description of the voltage dependence of axonal excitability in human cutaneous afferents
129. Motor-evoked potentials in response to fatiguing grip exercise in multiple sclerosis patients
130. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy
131. Activity-dependent conduction block in multifocal motor neuropathy
132. Effect of digitalis on clinical symptoms and conduction variables in patients with multiple sclerosis
133. Electrically active axons degenerate when exposed to nitric oxide
134. Exacerbated responses to oxidative stress by an Na+ load in isolated nerve terminals: The role of ATP depletion and rise of [Ca2+](i)
135. Cortical lesions in multiple sclerosis
136. Cortical deficits in multiple sclerosis on the basis of subcortical lesions
137. Cognitive function in primary progressive and transitional progressive multiple sclerosis. A controlled study with MRI correlates
138. Speed of information processing as a key deficit in multiple sclerosis: Implications for rehabilitation
139. Correlates of executive function in multiple sclerosis: The use of magnetic resonance spectroscopy as an index of focal pathology
140. Dynamic modulation of cerebral cortex synaptic function by nitric oxide
141. Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation
142. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons
143. Tripartite synapses: Glia, the unacknowledged partner
144. Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension
145. Ca2+-Zn2+ permeable AMPA or kainate receptors: Possible key factors in selective neurodegeneration
146. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
147. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures
148. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
149. Cytokine effects on glutamate uptake by human astrocytes
150. Glutamate excitotoxicity in a model of multiple sclerosis
151. Autoimmune encephalomyelitis ameliorated by AMPA antagonists
152. Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line
153. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
154. Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: Sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase
155. Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats
156. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
157. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats
158. Phosphodiesterase type 4 inhibitors: Potential in the treatment of multiple sclerosis?
159. Cannabinoids control spasticity and tremor in a multiple sclerosis model
160. Effects of cannabinoids on the immune system and central nervous system: Therapeutic implications
161. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
162. Loss of electrical exitability in an animal model of acute quadriplegic myopathy
163. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis
164. HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis
165. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination